Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Stock Rating Reaffirmed by SunTrust Banks, Inc.

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)‘s stock had its “buy” rating restated by equities research analysts at SunTrust Banks, Inc. in a report released on Monday, October 9th. They presently have a $30.00 target price on the real estate investment trust’s stock. SunTrust Banks, Inc.’s price objective would indicate a potential upside of 40.71% from the company’s previous close. SunTrust Banks also issued estimates for Sabra Healthcare REIT’s Q3 2017 earnings at $0.92 EPS, Q4 2017 earnings at $0.47 EPS, FY2017 earnings at $2.50 EPS, Q1 2018 earnings at $0.62 EPS, Q2 2018 earnings at $0.63 EPS, Q3 2018 earnings at $0.64 EPS, Q4 2018 earnings at $0.65 EPS, FY2018 earnings at $2.54 EPS and FY2019 earnings at $2.67 EPS.

SBRA has been the subject of a number of other research reports. Cantor Fitzgerald restated a “buy” rating and issued a $30.00 target price on shares of Sabra Healthcare REIT in a research note on Friday, September 8th. Capital One Financial Corporation assumed coverage on Sabra Healthcare REIT in a research note on Monday, September 25th. They set an “equal weight” rating and a $24.00 price objective for the company. BidaskClub lowered Sabra Healthcare REIT from a “sell” rating to a “strong sell” rating in a research note on Wednesday, August 16th. Zacks Investment Research upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Wednesday, August 2nd. Finally, Jefferies Group LLC reiterated a “buy” rating and set a $24.00 price objective (down previously from $25.00) on shares of Sabra Healthcare REIT in a research note on Wednesday, September 27th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the stock. Sabra Healthcare REIT currently has an average rating of “Hold” and a consensus target price of $25.30.

Shares of Sabra Healthcare REIT (NASDAQ SBRA) opened at 21.32 on Monday. The stock’s 50 day moving average price is $22.05 and its 200 day moving average price is $23.71. Sabra Healthcare REIT has a 12-month low of $19.30 and a 12-month high of $29.10. The company has a market capitalization of $1.40 billion, a PE ratio of 17.95 and a beta of 0.88.

ILLEGAL ACTIVITY NOTICE: “Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Stock Rating Reaffirmed by SunTrust Banks, Inc.” was first posted by BBNS and is the sole property of of BBNS. If you are accessing this report on another website, it was stolen and reposted in violation of US & international copyright laws. The legal version of this report can be viewed at https://baseballnewssource.com/markets/sabra-healthcare-reit-inc-sbra-rating-reiterated-by-suntrust-banks-inc/1704416.html.

Several large investors have recently bought and sold shares of SBRA. Bank of Montreal Can boosted its holdings in Sabra Healthcare REIT by 44.1% in the 1st quarter. Bank of Montreal Can now owns 3,893 shares of the real estate investment trust’s stock worth $109,000 after buying an additional 1,191 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Sabra Healthcare REIT by 14.2% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,799 shares of the real estate investment trust’s stock worth $106,000 after buying an additional 471 shares during the last quarter. Swiss National Bank boosted its holdings in Sabra Healthcare REIT by 1.9% in the 1st quarter. Swiss National Bank now owns 107,400 shares of the real estate investment trust’s stock worth $3,000,000 after buying an additional 2,000 shares during the last quarter. UBS Asset Management Americas Inc. boosted its holdings in Sabra Healthcare REIT by 28.7% in the 1st quarter. UBS Asset Management Americas Inc. now owns 133,525 shares of the real estate investment trust’s stock worth $3,729,000 after buying an additional 29,778 shares during the last quarter. Finally, Karp Capital Management Corp acquired a new stake in Sabra Healthcare REIT in the 1st quarter worth about $554,000. Hedge funds and other institutional investors own 99.26% of the company’s stock.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Analyst Recommendations for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston Astros Relying on Justin Verlander to Save Their Season
Houston Astros Relying on Justin Verlander to Save Their Season
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation


Leave a Reply

 
© 2006-2017 BBNS.